Our conditional serum response factor (SRF) knockout, Srf Cko , in the heart-forming region blocked the appearance of rhythmic beating myocytes, one of the earliest cardiac defects caused by the ablation of a cardiac-enriched transcription factor. The appearance of Hand1 and Smyd1, transcription and chromatin remodeling factors; Acta1, Acta2, Myl3, and Myom1, myofibril proteins; and calcium-activated potassium-channel gene activity (KCNMB1), the channel protein, were powerfully attenuated in the Srf CKO mutant hearts. A requisite role for combinatorial cofactor interactions with SRF, as a major determinant for regulating the appearance of organized sarcomeres, was shown by viral rescue of SRF-null ES cells with SRF point mutants that block cofactor interactions. In the absence of SRF genes associated with biomineralization, GATA-6, bone morphogenetic protein 4 (BMP4), and periostin were strongly up-regulated, coinciding with the down regulation of many SRF dependent microRNA, including miR1, which exerted robust silencer activity over the induction of GATA-6 leading to the down regulation of BMP4 and periostin.
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heart development ͉ microRNA ͉ periostin ͉ cardiogenesis ͉ GATA6 T he heart is the first organ to form in mammals, controlled by an exquisite program that results in the assembly of organized sarcomeres that rhythmically beat. First, molecular principles underlying sarcomerogenesis were based on the gene-switch paradigm in which nonmuscle actins are replaced by smooth muscle and cardiac ␣-actins in the heart-forming region (1, 2) . Serum response factor (SRF), identified by Treisman and colleagues (3) , and a MADS (MCM1, Agamous, Deficiens, serum response factor) box transcription factor may play a critical role in sarcomerogenesis, as deduced from transfection assays demonstrating the essential role of SRF binding sites, or CArG boxes, for switching on cardiac gene transcription, competition with negative acting YY1 and HOP, and cardiac restricted expression (reviewed in ref. 4) . Cardiac progenitors receiving the appropriate developmental cues switch on several cardiac-restricted transcription factors such as Nkx2-5, GATA-4, and myocardin that interact with SRF to activate many cardiac and smooth-muscle structural genes (reviewed in refs. 4, 5) . SRF target genes are also involved with contractility, cell movement, and cell growth signaling (6, 7) and the recently discovered microRNAs, required for normal heart development (8) .
The function of SRF in heart development in vivo has been obscured by the early lethality of SRF null mice before the onset of cardiogenesis (9) . Even recent SRF inactivation studies in the heart, performed through a conditional knockout strategy by using Cre recombinase driven by late expressing transgenic promoters such as, SM22␣, and or ␣/␤ myosin-heavy chains, failed to reveal an obligatory role for SRF in controlling the appearance of beating myocytes (10) (11) (12) . That failure is because SRF induced during early cardiogenesis is relatively stable and sarcomeres appeared even after Cre recombinase mediated ablation of the SRF genetic locus (12) . To dissect out SRF's role during early cardiac myocyte commitment and differentiation, we generated lineage-specific deletion of SRF with our Nkx2.5
Cre (13) and Srf LoxP/Loxp mice (14) in the HFR, well before SRF protein actually accumulated in the heart.
Results
The SRF Cardiac-Null Mutant Exhibited Nonbeating and Heart-Looping Defect. To block the appearance of SRF before the appearance of beating cardiac myocytes, we engineered a mouse that carried both Srf LacZ and Nkx2.5 Cre on chromosome 17 which was then bred to SRF Lox/Lox mice to generate a conditional SRF knockout (Srf Cko ) in the heart-forming region. The Srf Cko mutant genotyped as Srf LacZ/Flox :Nkx2.5Cre was first discernible at approximately 8.0 dpc (linear heart-tube stage) with a nonbeating heart tube (Fig. 1A) . Immunof luorescence staining with anti-SRF antibodies showed SRF staining in myocytes of haploid SRF mutant embryos and the absence of SRF in the Srf Cko embryo (Fig. 1 B-E) . This tubular structure misplaced the anterior portion of the developing out-f low tract in the Srf Cko mutant (Fig. 1 F and G) . By Ϸ8.5 dpc, severe ventricular dilation and cranially retained right ventricle/outf low tract were 2 common morphological defects of this motionless tubular heart ( Fig. 1 H and I) The outf low tract derived from second heart field (SHF) was undersized, as shown by Wnt11 expression ( Fig. 1 J and K, ref. 15 ), whereas cardiac fieldmarker genes Nkx2.5 (16) and Fgf10 (17) appeared unaffected ( Fig. 1 L-O) . copy indicated that neither aligned filaments nor Z disks that were formed in multiple Srf Cko cardiac mutants correlated well with the nonbeating heart ( Fig. 2 M-Q) . These ''paralyzed'' mutant hearts did not display any sarcomere signatures in multiple Srf Cko mutant samples.
The appearance of Smyd1, a cardiac and skeletal musclespecific chromatin-remodeling factor (18) failed to appear in the nascent Srf Cko mutant myocytes ( Fig. 3 A and B) . Expression of Tgf1/1, a LIM protein that serves as a cofactor with the androgen receptor and p300 (19) 
Srf
Cko mutant heart ( Fig. 3 C and D) . Expression of the Hand1 gene, a first heart-field maker, was reduced in the Srf Cko mutant ( Fig. 3 E and F) , and may have also contributed to ventricular dilation. Appearance of calcium-activated potassium-channel gene activity (KCNMB1) was blunted in the Srf Cko mutant hearts ( Fig. 3 G and H) . Many of these genes were validated for the presence of conserved CArG elements in their promoters (Fig. 3I) . Fig. S1 ]. Increased expression of wild-type SRF and mutants by the lentivirus system was sufficient to either rescue completely and or in part the cardiac myogenesis defect of Srf Ϫ/Ϫ ES cells (Fig.  4 B-D) . Microarray analysis and quantitative RT-PCR confirmed the rescue and enhanced expression of Hand1 and Smyd1, transcription and chromatin remodeling factors, Acta1, Acta2, Myl3, and Myom1, myofibril proteins, and Kcnmb1 excitation contraction coupling proteins by SRF replenishment in Srf Ϫ/Ϫ ES cells (Fig. 4  B and C) . Measurement of GATA4, myocardin, and MRTFs transcripts indicated that there were sufficient amounts of these factors to allow for gene activation in the presence of the SRF mutants (Fig. S2) . Moderate elevation of some structural gene expression was elicited by either SRF-145 or SRF-194, but neither mutant alone was sufficient to drive terminal cardiac myocyte differentiation, as determined by immunofluorescent staining of organized sarcomeres, microarray analysis, and beating cardiac myocytes (Fig. 4 D and E, and Movies S1-S4). Given the fact that SRF directed the appearance of beating myocytes from SRF-null ES cells, we conclude that the inability of the SRF interactiondefective mutants to rescue myogeneis highlighted the significance of these cofactor associations in cardiac myogenesis and not their absence.
SRF, a Biomineral and Extracellular Gene Program Silencer.
Analysis of cardiac Srf Cko also revealed strong up-regulation of GATA-6, bone morphogenetic protein 4 (BMP4), and periostin (Postn) genes associated with biomineral formation (Fig. 5A) , in the regions of the endocardium destined to become the septum and outflow tract and the SHF (Fig. 5 B-G) . Postn is expressed in the mesenchymalderived cardiac fibroblasts, valvular attachment apparatus, and epicardial/pericardial structures, but is absent from the cardiomyocyte lineage (20) . Expression of BMPs in the myocardium is critical for the induction of Postn (21) . mef2c-AHF-Cre transgenic mice were used to direct the expression of Cre recombinase exclusively in the anterior heart field and its derivatives to conditionally ablate the Bmp4 Lox/Lox gene. Endothelial and myocardial components of the outflow tract, right ventricle, and ventricular septum were shown to be derivatives of mef2c-AHF-Cre expressing cells (22) . The mef2c-AHF-Cre transgene-induced knockout of Bmp4 Lox/Lox in the E10.5 mouse embryonic-mouse heart blocked the appearance of Postn in the outflow tract ( Fig. 5 H and I) . In addition, closely related BMP-2 induced periostin expression in cardiac-cushion mesenchymal cells (21), thus support the role of BMP signaling, leading to periostin expression. Periostin may also suppress myocyte differentiation. Conversely, periostin deletion might result in enhanced and/or ectopic myocyte differentiation. To distinguish the appearance of cardiomyocytes from the Postn-expressing noncontractile tissues, we made use of the ␣MHC-EGFP reporter mice (23) that express EGFP exclusively in cardiac muscle in the background of targeted-null (Postn LacZ ) neonatal mice. Surviving adult Postn LacZ -null hearts contained ectopic ␣MHC EGFP expression, as EGFP-positive islands in the null epicardium (n ϭ 9:13 Postn LacZ null ␣MHC EGFP hearts examined; Fig. 5J ). This was confirmed via costaining with the myocardialmarker MF20 in Postn LacZ null, but not wild-type, epicardium (not shown).
SRF Directs the Expression of Many MicroRNAs Including miR1
. SRF may exert gene silencing activities through its regulation over microRNAs (miRNAs). In day 9.5 Srf Cko embryonic-mutant hearts, Յ20 miRNAs, each of which contain at least 1 conserved CArG element in their promoters, were down-regulated in comparison to control heart samples (Fig. 6A) . Among these miRNAs, miR-1 (8) was shown to be controlled by SRF through its 3 CArG boxes (24) . In addition, mice lacking miR-1-2 have a spectrum of cardiac abnormalities also allowed for the induction of GATA-6 (8). Greater than 90% of miR-1 RNA transcripts were blocked in the Srf Cko hearts, whereas GATA6 mRNA levels increased over 18 fold ( Fig. 6 B and C) . Thus, tissue-specific expression of miRNAs regulated by SRF at the transcriptional level may have a strong regulatory activity over the noncontractile endocardial/epicardial gene activity.
miR-1 Blocked GATA6 and Periostin Expression.
To test this idea, we evaluated the role of SRF in regulation of miR-1 in the SRF lentiviral rescue of Srf-null ES cells (Fig. 6 ). Viral-expressed SRF induced about a 30-fold increase in miR-1 RNA, as shown by quantitative RT PCR analysis (Fig. 6D) . We observed increased levels of GATA6 (BMP2:4; data not shown) and periostin in Srf-null ES cells, and stable transfectants of these ES cells with miR-1 significantly repressed GATA6 and Postn expression, whereas miR-133, the miR-1 bicistronic partner, failed to inhibit their expression (Fig. 6 E and F) . Of the key biomineralization genes, only the well-conserved sites in mouse and rat GATA6 3ЈUTR, are favorably accessible, according to the algorithm reported by Zhao et al. (8;  (Fig. S3) . MiR-1 sites were not detected in Postn; thus, miR1 indirectly inf luenced Postn expression most likely through the silencing of GATA6. 
Discussion

SRF Orchestrates Cardiac Myogenesis Through Multiple Levels of
Regulation. Our study provides inconvertible evidence that SRF activity controls sarcomerogenesis in higher vertebrates, as modeled in the schematic diagram in Fig. 6G . Recently, Fukushige et al., (25) demonstrated that UNC-120, the C. elegans equivalent of SRF, was required to initiate a body-wall muscle program in naive early blastomeres and to drive muscle-structural gene activity. The unc-120-null mutants exhibited low-level myofilament protein production. The ability for SRF to be the universal ''myogenic driver'' was totally abrogated in the Srf-null cells and supports the concept that SRF resides at a high point in the regulatory hierarchy governing sarcomerogenesis from worms to mammals. Additionally, SRF activity was also controlled to a large extent through combinatorial factor interactions with tissue-specific regulatory cofactors and was supported by our rescue of Srf null ES cells with lentiviral-expressed SRF-point mutants that blocked co-factor association, but not DNA binding activity. Because SRF mutants were incapable of restoring sarcomerogenesis, our data supports the claim that SRF plays an obligatory role in cardiac myogenesis with a requirement for SRF cofactor interactions.
In the absence of Srf, we observed the strong up-regulation of biomineral and extracellular matrix-gene activity. GATA6 contributes to septal and valvular development via its direct transcription target, BMP4, leading the induction of Postn (26) . The deletion of the BMP type 1A receptor in the endocardium also resulted in failed cushion formation, indicating that BMP signals directly to cushion-forming endocardium to induce epithelial-mesenchyme transition (27) . Transformation of atrioventricular (AV) canal endocardium into invasive mesenchyme correlates spatially and temporally with the expression of BMPs in the atrioventricular myocardium crucial for the induction of Postn (28) . Kühn et al. (29) showed that periostin-induced cardiomyocyte cell-cycle reentry and mitosis, whereas periostin expression was associated with improved ventricular remodeling and myocardial function (30) . We showed that conditional abrogation of periostin by targeted gene-deletionactivated cardiac-cell differentiation, as exemplified by the ectopic expression of the ␣MHC EGFP -fluorescent gene reporter (Fig. 5 ).
SRF, a Powerful Silencer Directs the Expression of Many miRNAs,
Including miR-1. SRF may also direct the expression of many miRs that inhibit the expression of cardiac regulatory factors that influence cardiac lineage specification. Twenty miRs were significantly down-regulated in the SRF Cko -mutant heart (Fig. 5A) . As shown here, miR-1 RNA transcripts were dependent upon SRF expression and were blocked in Srf Cko hearts. Rescue of SRF-null ES cells with viral expressed SRF induced Ϸthirty-fold increase in miR-1 RNA (Fig. 6 ). Increased levels of GATA6 and Postn in Srf-null ES cells were also attenuated by miR-1, but not by miR-133, the miR-1 bicistronic partner. Thus, miR-1 appears to play an important role in regulating GATA6 expression leading to endocardial/epicardial gene silencing. In addition, Chen et al. (31) showed that expression of miR-133 repressed myoblast differentiation by repressing SRF expression. Thus, miR-133 is controlled by SRF, yet directs a negative regulatory loop through inhibiting SRF translation (Fig.  6G) . Possibly, the delicate balance of SRF-directed silencing of miRNA activity may be even more profound in human heart disease. Chang et al. (32) found SRF was cleaved by caspase 3 in human heart failure and generated its dominant-negative SRF-N in the failing human myocardium. Thus, during the onset of heart failure, cleaved SRF will likely interfere with SRF's global role in controlling genes required for sarcomerogenesis, but may also hinder the expression of SRF-dependent miRNAs that silence gene activities causing dysregulation of normal cardiac performance. 
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